Influence of hypercholesterolemia and endothelin-3 pre-treatment on the effects of shear forces on platelet aggregation and cyclic GMP content

Atherosclerosis

Volumn 143, Issue 1, 1999, Pages 91-97

  Gagnet, C ^a   Devynck, M A ^b   Simon, A ^a   Levenson, J ^a  

^a Centre de Medecine Preventive   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

cGMP content; Endothelin; Hypercholesterolemia; Platelet aggregation; Shear forces

Indexed keywords

CYCLIC GMP; ENDOTHELIN; ENDOTHELIN 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

BLOOD PLATELETS; CYCLIC GMP; ENDOTHELIN-3; HEMORHEOLOGY; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PLATELET AGGREGATION; STRESS, MECHANICAL;

EID: 0033052076     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00282-2     Document Type: Article

References (42)

1. Baumgartner HR, Turitto V, Weiss HJ. Effects of shear rate on platelet interaction with subendothelium in citrated and native blood. J Lab Invest. 95:1980;208-21.
2. Kroll MH. Platelets and shear stress. Blood. 88:1996;1525-41.
3. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein GPIb initiates calcium influx associated with aggregation. Blood. 80(1):1992;113-120.
4. Booth WJ, Andrews RK, Castaldi PA, Berndt MC. The interaction of von Willebrand Factor and the platelet glycoprotein IL-IX complex. Platelets. 1:1990;169-76.
5. Vane JR, Botting RM. Formation by the endothelium of prostacyclin, nitric oxide and endothelin. J Lipid Mediat. 6:1993;395-404.
6. Frangos JA, Eskin SG, Mc Intire LV. Flow effects on prostacyclin production by cultured human endothelial cells. Science. 227:1985;1477-79.
7. Grabovski EF, Jaffe EA, Weksler BB. Prostacyclin production by cultured endothelium cell monolayers exposed to step increases in shear stress. J Lab Clin Med. 105:1985;36-43.
8. Frangos JA, Huang TY, Clark CB. Steady shear and step changes in shear stimulate endothelium via independent mechanisms-superposition of transient and sustained nitric oxide production. Biochem Biophys Res Commun. 224:1996;660-65.
9. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-69.
10. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 76:1995;536-43.
11. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Hemodynamic shear stress stimulates endothelin production by cultured endothelium cells. Biochem Biophys Res Commun. 161:1989;859-64.
12. Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increase flow. Biochem Biophys Res Commun 1990;170:649-56.
13. Nollert MU, Diamond SK, McIntyre LV. Hydrodynamic shear stress and mass transport modulation of endothelial cell metabolism. Biotechnol Bioeng. 38:1991;588-602.
14. Blockmans D, Deckmyn H, Vermylen J. Platelet activation. Blood Rev. 9:1995;143-56.
15. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confumation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA. 93:1996;1480-85.
16. 2+ mobilization in human platelets. Br J Pharmacol. 106:1992;966-71.
17. 2+ concentrations in essential hypertension. Hypertension. 22:1993;853862.
18. Touyz RM, Schiffrin EL. Role of protein kinase C in the anti-aggregatory effects of endothelin-1 on human platelets. Clin Sci. 88:1995;277-83.
19. 2+ concentration in human hypertension. Clin Sci. 79:1990;613-18.
20. Mazeaud M, Levenson J, Le Quan Sang KH, Simon A, Devynck MA. Platelet aggregation and in vivo shear forces. Thromb Haemostasis. 71:1994;26-31.
21. 2+ mobilization and cyclic GMP content in humans platelets. Eur J Pharmacol. 310:1995;67-72.
22. Cooper MB, Tan KC, Betteridge DJ. Platelet transmembrane signalling responses to collagen in familial hypercholesterolaemia. Eur J Clin Invest. 24:1994;737-43.
23. Hochgraf E, Levy Y, Aviram M, Brook JG, Cogan U. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism. 43:1994;11-17.
24. Mazeaud M, Driss F, Le Quan Sang KH, Duranthon V, Levenson J, Devynck MA. Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients. Atherosclerosis. 94:1992;201-11.
25. Luscher TF, Dubey RK. Endothelium and platelet-derived vasoactive substances: Role in the regulation of vascular tone and growth. Laragh Brenner Pathophysiology, Diagnosis and Management. 1:1995;609-30 Raven Press, New York.
26. Boulanger CM, Tanner FC, Hahn AWA, Werner A, Luscher TF. Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 70:1992;1191-1197.
27. Watt PAC, James MA, Lawrence IG, Bing RF, Thurston H. The effects of hypercholesterolemia on structure and function of human resistance arteries. J Hypertens. 14:1996;122.
28. Lugnier C, Schoeffler P, Le Bec A, Strouthou E, Stoclet JC. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol. 35(10):1986;1743-1751.
29. Stein EA. Tietz NW Nutrition. Fundamentals of Clinical Chemistry. 72:1987;248-54 WB Saunders, Philadelphia, Pa.
30. Assmann C, Schriewer H, Schmitz G, Hagele E. Quantification of high-density lipoprotein cholesterol by precipitation with phosphotungstic acid. Clin Chem. 29:1983;2026-30.
31. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 71(5):1988;1366-1374.
32. Brook G, Winterstein G, Aviram M. Platelet function and lipoprotein levels after plasmaexchange in patients with familial hypercholesterolemia. Clin Sci. 64:1983;637-42.
33. Devynck MA. Hypercholesterolemia and platelet hyperreactivity. Nutr Metab Cardiovasc Dis. 4:1994;119-121.
34. 2+ and membrane dynamics in patients with primary hypercholesterolemia; Effects of pravastatin. Arterioscl Thromb Vasc Biol. 15:1995;759-64.
35. Bidlingmeyer M, Kaeser P, Perret F, Darioli R, Waeber B, Brunner HR, Burnier M. Effect of simvastatin on serum cholesterol and platelet free calcium in nonobese, nonhypertensive patients with hyperlipoproteinemia. Nutr Metab Cardiovasc Dis. 4(3):1994;122-127.
36. Chen LY, Mehta P, Metha JL. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effects of oxidized LDL on platelet function. Circulation. 93:1996;1740-46.
37. Kochhar N, Kaul D. Molecular link between membrane cholesterol and cyclic nucleotides in human platelets. Blood Coag Fibrin. 3(2):1992;215-219.
38. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-15.
39. Masaki T, Vane JR, Vanhoutte PM. International Union of Pharmacology. Nomenclature of endothelin receptors. Pharmacol Rev. 46:1994;137-42.
40. 2+-ATPase inhibitors in human platelets. Br J Pharmacol. 114:1995;524-30.
41. 2+ content of platelet internal stores. Biochem Biophys Res Commun. 210:1995;889-97.
42. Dockrell ME, Webb DJ, Williams BC. Activation of the endothelin B receptor causes a dose dependent accumulation of cyclic GMP in human platelets. Blood Coagul Fibrin. 7:1996;178-80.